Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a…

Cohort studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie· Jul 2026

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Yung-Ray Hsu, Ming-Shan Cheng, Jia-Kang Wang

Read paper

UveitisCohort studyTreatmentQ1IF 3.1

High-dose topical antiviral therapy linked to fewer flare-ups in cytomegalovirus eye inflammation

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Yung-Ray Hsu … Jia-Kang Wang

Graefe's archive for clinical and experimental ophthalmology · Jul 2026 · Q1 in Ophthalmology

Purpose

To evaluate criteria-based long-term structural outcomes and dose-dependent antiviral effects in cytomegalovirus anterior uveitis (CMV AU).

Methods

From a 10-year ocular inflammation registry comprising 1,404 patients, 79 eyes from 67 patients with PCR-confirmed CMV AU were identified (mean follow-up, 48 ± 38 months).

n = 1,404 patients

Results

high-dose therapy cut eye flare-ups more than low-dose treatment

More results

The mean age was 56.5 ± 15.5 years, and 82.1% had unilateral disease.

Median diagnostic delay was 33 months; 20.9% required repeat aqueous taps.

Glaucoma rose from 30.3% to 62.0% and ECCD loss from 27.8% to 57.0% during follow-up.

Kaplan-Meier analysis showed a median time of 9 years from symptom-onset to manifest glaucoma.

“

Conclusion

CMV AU poses significant long-term structural risk despite good short-term control. Early criteria-based treatment and high-dose antivirals reduce relapse, while lifelong maintenance is required in eyes with advanced disease.

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Long-term structural impact and antiviral efficacy of cytomegalovirus anterior uveitis - results from a 10-year ocular inflammation registry.

Related papers